Gliptins, a novel class of antidiabetics, are dipeptidyl peptidase-4 inhibitors (DPI-4) for improving β-cell health and controlling blood glucose levels in diabetes mellitus type 2 [13]. This evidence concerns the gene DPP4 and diabetes mellitus.